Skip to main content
Harvey Pass, MD, Thoracic Surgery, New York, NY

HarveyIPassMD

Thoracic Surgery • New York, NY

Adult General Thoracic Surgery, Thoracic Surgical Oncology, Cardiovascular Surgery

Professor of Surgery, NYU School of Medicine; Stephen E. Banner Professor of Thoracic Oncology; Vice-Chair Research, Department of Cardiothoracic Surgery; Division Chief, General Thoracic Surgery

Join to view full profile

Dr. Pass is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Pass' full profile

Already have an account?

  • Office

    530 First avenue, Cardiothoracic, 9V
    7th Floor
    New York, NY 10016
    Phone+1 914-330-4707
    Fax+1 212-263-2042

Education & Training

  • Medical University of South Carolina
    Medical University of South CarolinaFellowship, Thoracic Surgery, 1980 - 1982
  • University of Mississippi Medical Center
    University of Mississippi Medical CenterResidency, Surgery, 1977 - 1980
  • Duke University Hospital
    Duke University HospitalResidency, Surgery, 1973 - 1975
  • Duke University School of Medicine
    Duke University School of MedicineClass of 1973

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2005 - 2026
  • MI State Medical License
    MI State Medical License 1996 - 2006
  • SC State Medical License
    SC State Medical License 1980 - 1983

Awards, Honors, & Recognition

  • Top Doctors: New York Metro Area Castle Connolly, 2007-2016
  • New York Magazine: Top Doctors Castle Connolly, 2006-2016
  • America's Top Doctors for Cancer Castle Connolly, 2005-2016
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Epigenetically Regulated PAX6 Drives Cancer Cells Toward a Stem-like State via GLI-SOX2 Signaling Axis in Lung Adenocarcinoma  
    William N Rom, Harvey I Pass, Zahra Maleki, Nature
  • A Gene Expression Classifier from Whole Blood Distinguishes Benign from Malignant Lung Nodules Detected by Low-Dose CT  
    Anil Vachani, William N Rom, Gerard Criner, Harvey Pass, Clinical Cancer Research
  • Airway Microbiota Is Associated with up-Regulation of the PI3K Pathway in Lung Cancer  
    Benjamin G Wu, Harvey Pass, William N Rom, Daniel H Sterman, Vivek Murthy, Martin J Blaser, Michael D Weiden, Leopoldo N Segal, ATS Journals

Authored Content

  • Stage Dependence, Cell-Origin Independence, and Prognostic Capacity of Serum Glycan Fucosylation, β1–4 Branching, β1–6 Branching, and α2–6 Sialylation in CancerNovember 2017

Press Mentions

  • Life-Saving New Approaches for Mesothelioma Cancer Recommended
    Life-Saving New Approaches for Mesothelioma Cancer RecommendedMay 4th, 2022
  • The Best Biomarkers for Mesothelioma Diagnosis, Prognosis, & Monitoring
    The Best Biomarkers for Mesothelioma Diagnosis, Prognosis, & MonitoringJuly 27th, 2020
  • ‘It's a Big Deal’: Surgeon Group Studying Thoracic Disease Is Growing
    ‘It's a Big Deal’: Surgeon Group Studying Thoracic Disease Is GrowingJanuary 9th, 2020
  • Join now to see all

Grant Support

  • The North American Mesothelioma ConsortiumNational Cancer Institute2010–2011
  • Clinical CoreNational Cancer Institute2006–2010
  • American/Australian Mesothelioma ConsortiumNational Cancer Institute2005–2008

Professional Memberships

Dr. Harvey Pass, Dr. Harvey Pass, MD, Dr. H Pass, Dr. Harvey I Pass